The paper links three layers: voltage β phosphatidylserine/Ras β ERK β mitosis. Depolarization of U2OS cells with 15 mM KβΊ increased cytokinesis (p=0.016), an effect abolished by the MEK inhibitor U0126 (p=0.0040), placing MEK-ERK causally upstream . FRET imaging (EKAREV) revealed graded ERK activation: near-maximal at 145 mM KβΊ, ~50β60% at 30 mM, and heterogeneous with non-responders at 15 mM (Pearson r=0.54 vs log[KβΊ]). Critically, perforated patch-clamp confirmed voltage itself, not secondary effects, drives ERK: β40 mV failed, β20 mV activated, and 0 mV reached ~88 Β± 35% of EGF-maximal activity, with ERK deactivating within ~1 min of repolarization . FLIM-FRET showed phosphatidylserine nanoclustering and Ras activation within ~2 min of depolarization, preceding ERK, and fendiline-mediated PS depletion markedly blunted ERK activation (p=4.4Γ10β»βΉ) .
Note: values for 30K, 15K, and β20 mV are approximate ranges stated in the paper text, not exact figure-derived numbers.
Strengths: Combining single-cell FRET kinetics with voltage-clamp electrophysiology is a genuinely rigorous design; the patch-clamp data exclude perfusion artifacts and show ERK acts as an analog, reversible voltage readout rather than an on/off switch. Multi-line replication (U2OS, HEK293T, HeLa, A431) and proper controls (perfusion-only, hypotonic shock, CaΒ²βΊ-free) strengthen the claim .
Cautions (BGPT critical appraisal): (1) The authors themselves note reliance on the Nernst equation for perfusion-based estimates β a partially addressed limitation, mitigated only by the HEK293T patch data, which cover a narrow voltage range (β80 to 0 mV in one cell type). (2) Fendiline is not PS-specific (it inhibits acid sphingomyelinase and can have off-target CaΒ²βΊ channel effects), so the PS-necessity claim would benefit from genetic PS-synthesis knockdown. (3) Single-cell n per condition is small (15β23 cells, 2β6 experiments), and the claim of a "universal" mechanism rests on four cancer-derived lines β non-transformed primary cells are untested. (4) Mitosis data show depolarization and FBS effects are non-additive, suggesting a plateau; whether physiological depolarization events in vivo reach the required thresholds is unknown. (5) The claimed link to Zhou et al.'s PS/K-Ras framework is correlative here; direct visualization of K-Ras relocalization in this system is absent.
What would falsify the model: PS-synthesis-conditional cells showing intact voltage-gated ERK activation despite PS depletion; non-transformed primary cells lacking voltage-dependent ERK activation; or failure of ERK activity to track voltage in a broader panel of resting potentials.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.